Exploration of Targeted Anti-tumor Therapy is a peer-reviewed english-language open-access journal published by Open Exploration Publishing Inc. in China, operating under an open-access model since 2020. The journal covers Internal medicine.
Authors are required to pay an article processing charge to publish in Exploration of Targeted Anti-tumor Therapy; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Exploration of Targeted Anti-tumor Therapy has published 363 articles. Articles are minted with DOIs through the prefix 10.37349.
Keywords
cancer, target therapy, precision oncology, diagnosis, biomarkers, cancer mechanisms
At a glance
- Publisher
- Open Exploration Publishing Inc.
- Country
- China
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2020
- DOI prefix
10.37349
ISSN
- electronic
- 2692-3114
Frequently asked questions
Is Exploration of Targeted Anti-tumor Therapy peer-reviewed?
Does Exploration of Targeted Anti-tumor Therapy charge an article processing charge (APC)?
What subjects does Exploration of Targeted Anti-tumor Therapy publish?
What languages does Exploration of Targeted Anti-tumor Therapy accept?
What is the ISSN of Exploration of Targeted Anti-tumor Therapy?
2692-3114 (electronic).